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Abstract. 
 
Stimulation of 
 
b
 
-adrenergic receptors acti-
vates type I and II cyclic AMP–dependent protein ki-
nase A, resulting in phosphorylation of various proteins 
in the heart. It has been proposed that PKA II com-
partmentalization by A-kinase–anchoring proteins 
(AKAPs) regulates cyclic AMP–dependent signaling in 
the cell. We investigated the expression and localiza-
tion of AKAP100 in adult hearts. By immunoblotting, 
we identified AKAP100 in adult rat and human hearts, 
and showed that type I and II regulatory (RI and II) 
subunits of PKA are present in the rat heart. By immu-
nofluorescence and confocal microscopy of rat cardiac 
myocytes and cryostat sections of rat left ventricle pap-
illary muscles, we localized AKAP100 to the nucleus, 
sarcolemma, intercalated disc, and at the level of the 
Z-line. After double immunostaining of transverse cross-
sections of the papillary muscles with AKAP100 plus 
 
a
 
-actinin–specific antibodies or AKAP100 plus ryano-
dine receptor–specific antibodies, confocal images 
showed AKAP100 localization at the region of the trans-
verse tubule/junctional sarcoplasmic reticulum. RI is dis-
tributed differently from RII in the myocytes. RII, but 
not RI, was colocalized with AKAP100 in the rat heart. 
Our studies suggest that AKAP100 tethers PKA II to 
multiple subcellular compartments for phosphorylation 
of different pools of substrate proteins in the heart.
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S
 
timulation 
 
of 
 
b
 
-adrenergic receptors results in acti-
vation of the cAMP-dependent signaling pathway.
cAMP-dependent protein kinase (PKA)
 
1
 
 is a tet-
rameric holoenzyme consisting of two catalytic (C) and
two regulatory (R) subunits. When four molecules of
cAMP bind to inactive PKA, the C subunits are released
from the regulatory subunit-cAMP complex (Taylor et al.,
1990). By phosphorylating substrate proteins, PKA regu-
lates a broad range of cellular responses. Two classes of R
subunit exist—RI and RII—that form type I and type II
PKA (PKA I and II), respectively. PKA I is predomi-
nantly cytosolic, whereas up to 75% of PKA II is compart-
mentalized to specific cellular compartments via binding
to a family of A-kinase–anchoring proteins (AKAPs; Ru-
bin, 1994). Recent studies demonstrated that RI may also
bind to AKAPs (Burton et al., 1997; Huang et al., 1997).
AKAPs can bind other enzymes, thus forming a scaffold
for a multi-enzyme complex. For example, AKAP79 can
simultaneously bind PKA II, calcium- and calmodulin-
dependent protein phosphatase-2B, and protein kinase C
(PKC; Klauck et al., 1996), and AKAP250 contains bind-
ing sites for both RII and PKC (Nauert et al., 1997). It has
been proposed that AKAPs serve as scaffolding proteins
in PKA- and PKC-signaling pathways, permitting sequen-
tial activation of each enzyme and tethering of enzymes
close to their substrates (Faux and Scott, 1996).
By using radioactively labeled RII in an overlay assay
(Lohmann et al., 1984), several AKAPs have been identi-
fied in various tissues (Dell’Acqua and Scott, 1997). Gen-
erally, AKAPs were named according to the apparent mo-
lecular weight of the proteins on SDS-PAGE gels. AKAPs
have been localized to different subcellular compartments;
e.g., sAKAP84 to mitochondria, AKAP220 to peroxi-
somes, AKAP85 to Golgi, MAP2 in microtubules and
AKAP95 in nucleus (Dell’Acqua and Scott, 1997). Distri-
bution of AKAPs in multiple subcellular compartments
has not been reported. Scott and coworkers recently pro-
posed the PKA-targeting hypothesis whereby each AKAP
tethers the PKA complex or other signaling enzymes to a
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particular organelle or location in the cell (Scott, 1997).
According to this hypothesis, subcellular location of the
AKAP/PKA II complex is determined by the targeting do-
main of the AKAP molecule.
In cardiac muscle cells, PKA has broad substrate speci-
ficity. Major PKA substrates in the heart are L-type Ca
 
2
 
1
 
channels (Tsien et al., 1986) in the sarcolemma, primarily
in the transverse (T) tubules (Piper and Isenberg, 1989),
ryanodine receptors (RyR) in the junctional sarcoplasmic
reticulum (SR; Takasago et al., 1991; Takasago et al.,
1989), phospholamban (Garvey et al., 1988), and Cl
 
2
 
channel in the SR (Kawano et al., 1992), troponin I in the
thin filaments, and C-protein in the thick filaments
(Garvey et al, 1988). Since each of these PKA substrates
has a different subcellular location, AKAP-dependent
PKA compartmentalization is likely to be an important
regulatory mechanism for 
 
b
 
-adrenergic signaling in the
heart.
However, knowledge about AKAPs in the heart is very
limited. In 1995, Scott’s laboratory isolated an AKAP
cDNA by screening a human brain cDNA library with ra-
dioactively labeled RII (McCartney et al., 1995). The iden-
tified AKAP cDNA encodes a 78-kD protein. Because an-
tibodies against this AKAP recombinant recognized a
protein of 
 
z
 
100 kD in rat embryonic muscle cell lines, the
AKAP was named AKAP100. AKAP100 mRNA was
found to be abundant in human heart and skeletal muscle.
In the rat embryonic cardiac H9c2 cell line, AKAP100 and
RII colocalized to the perinuclear region (McCartney et al.,
1995) at the same location as the signal sequence receptor,
a marker of the rough ER (Krijnse-Locker et al., 1995).
Embryonic hearts undergo significant changes during mat-
uration, including a switch of protein isoform expression,
development of the T-tubular system, and SR network and
formation of sarcomeres. H9c2 cells do not have the orga-
nized sarcomere structures of differentiated adult cardiac
myocytes (Hescheler et al., 1991); therefore, the embry-
onic cardiac cell line cannot be considered representative
of the highly differentiated cardiac myocytes of the adult
heart. The present study investigated the expression and
localization of AKAP100 in adult hearts.
 
Materials and Methods
 
Antibodies
 
Polyclonal rabbit IgG antibodies against human AKAP100 recombinant
protein and polyclonal goat IgG antibodies against mouse RII recombi-
nant were obtained from Upstate Biotechnology Inc. (Lake Placid, NY).
RI-specific monoclonal antibody (clone 18) was obtained from Transduc-
tion Laboratories (Lexington, KY). RyR-specific monoclonal antibody
(clone C3-33) was obtained from Affinity Bioreagents (Golden, CO). The
specificity of the anti-RyR antibody has been previously described (Carl
et al., 1995). An 
 
a
 
-actinin–specific monoclonal antibody (clone EA-53),
obtained from Sigma Chemical Co. (St. Louis, MO), has been used to
characterize 
 
a
 
-actinin in rat cardiac myocytes (Sussman et al., 1994). A
monoclonal antibody against the 6 histidine tag was obtained from
CLONTECH Laboratories, Inc. (Palo Alto, CA). HRP-conjugated rabbit
anti-mouse antibodies, HRP-goat anti–rabbit antibodies, and HRP-rabbit
anti–goat antibodies were purchased from Sigma Chemical Co. FITC-con-
jugated donkey anti–mouse antibodies, FITC-donkey anti–goat antibod-
ies, and lissamine rhodamine B sulfonyl chloride (LRSC)–conjugated
donkey anti–rabbit antibodies were obtained from Jackson ImmunoRe-
search Laboratories, Inc. (West Grove, PA). FITC-phalloidin was pur-
chased from Molecular Probes, Inc. (Eugene, OR).
 
Preparation of Rat Left Ventricular Myocytes
 
All procedures involving animals follow the Guide for the Care and Use
of Laboratory Animals (Institute of Laboratory Animal Resources, 1996).
The Animal Care Core Facility of the Cleveland Clinic Foundation is ac-
credited by the American Association for the Accreditation of Laboratory
Care.
Cardiac myocytes were isolated from the left ventricle of adult Sprague-
Dawley rats (purchased from Taconic Farms, Inc. [Germantown, NY] at
20–30 wk of age) by collagenase digestion using a modified Langendorff
perfusion according to methods previously described (McConnell et al.,
1997). The isolated myocytes were resuspended in O
 
2
 
-saturated Hepes-
buffered saline containing 118 mM NaCl, 4.8 mM KCl, 1.2 mM MgCl
 
2
 
,
1.25 mM CaCl
 
2
 
, 11 mM glucose, 0.68 mM glutamine, 5 mM pyruvate, and
25 mM Hepes, pH 7.35, supplemented with 0.1 mM Eagle’s minimum es-
sential medium, basal medium Eagle’s vitamin, and amino acid solution
at room temperature. The viability of the isolated cardiac myocytes was
typically 75–85%, as determined by rod-shaped morphology and lack of
granulation or blebs. After isolation, the ventricular myocytes were imme-
diately used either for extraction of myocardial proteins or immunolocal-
ization.
 
Myocardial Protein Preparations
 
Expression of AKAP100 was determined in an adult rat cardiac myocyte
extract. Preparation of the crude protein extract followed methods previ-
ously described (McCartney et al., 1995). In brief, the isolated rat left ven-
tricular myocytes were collected from the Hepes-buffered saline suspen-
sion by centrifugation at 500 
 
g
 
 for 2 min at room temperature. The
myocytes were then resuspended in ice-cold Buffer A (50 mM Tris-HCl,
pH 7.5, 0.1% Triton X-100, 0.05 mM DTT, 0.5 mM MgCl
 
2
 
, 0.125 mM
EDTA, 5 
 
m
 
g/ml antipain, 10 
 
m
 
g/ml leupetin, 5 
 
m
 
g/ml pepstatin, and 43 
 
m
 
g/ml
PMSF), and were sonicated for 30 s (three bursts of 10 s each) on ice fol-
lowed by centrifugation at 12,000 
 
g
 
 for 15 min at 4
 
8
 
C. The protein extract
in the supernatant was separated from the pellets and subjected to immu-
noblot analysis. In addition, expression of AKAP100 was also determined
in adult rat and human heart tissues. Human heart tissue was obtained
from an unmatched organ donor (male, age 40) from LifeBanc of North-
east Ohio (Cleveland, Ohio). For preparation of heart homogenates, left
ventricle from an adult Sprague-Dawley rat or 0.8 g of left ventricle from
the human donor was homogenized in 3 ml of ice-cold Buffer A, followed
by sonication as above. The homogenates were filtered by using four layers
of cheesecloth, and the large tissue debris was removed. The homogenates
were then subjected to immunoblot and immunoprecipitation analyses as
described below. To characterize the specificity of anti-RI and anti-RII
antibodies, soluble rat left ventricle extracts prepared according to meth-
ods previously described (Jahnsen et al., 1985) were used in the immuno-
blot analysis.
 
Immunoblot, Immunoprecipitation, and RII
Overlay Assays
 
Immunoblot analysis was performed to determine expression of
AKAP100 in adult hearts, and to characterize the antibody specificity.
Myocardial proteins were separated on 10% polyacrylamide gels by SDS-
PAGE under reducing conditions using the Bio-Rad electrophoresis sys-
tem (Mini-Protean II, 8 
 
3 
 
7.3 cm; Bio-Rad Laboratories, Hercules, CA)
or the Hoefer electrophoresis system (SE 600, 18 
 
3 
 
16 cm; Pharmacia Bio-
tech, Inc., Piscataway, NJ) followed by electrical transfer. After blocking
with nonfat dry milk, the nitrocellulose membrane was incubated with pri-
mary antibodies followed by incubation with HRP-conjugated secondary
antibodies. The immunoblot was then developed by enhanced chemilumi-
nescence (ECL) assay followed by autoradiography. Alternately, protein
bands were visualized by color development using the 4-chloro-1-naph-
thol substrate. The protein concentration of the samples was determined
by the Bio-Rad protein assay. Approximately 50 
 
m
 
g and 100 
 
m
 
g of myo-
cardial proteins were loaded on each lane of the minigel and the large gel,
respectively. To determine the apparent molecular weight of AKAP100,
unstained Perfect Protein Markers™ from Novagen, Inc. (Madison, WI)
were also run on the SDS-PAGE gels. These unstained protein markers
consist of precisely sized recombinant proteins carrying an S
 
•
 
Tag™ pep-
tide that can be visualized by using HRP-conjugated S-protein (Novagen,
Inc. Madison, WI) in the immunoblot analysis.
Dilution of primary and secondary antibodies followed supplier’s in-
structions. To characterize human AKAP100 recombinant protein, the 
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anti-AKAP100 polyclonal antibodies used in immunoblot analysis were
preabsorbed by using nitrocellulose membrane bound with 
 
Escherichia
coli
 
 bacterial antigens. In addition, 
 
E. coli
 
 bacterial lysates containing hu-
man AKAP100 recombinant were used to deplete AKAP100-specific
IgGs. The depleted antibodies were then used in immunoblot analysis to
characterize AKAP100 protein in adult hearts. As a complementary ex-
periment, the polyclonal human AKAP100-specific IgG antibodies were
affinity-purified by using Western blot strips immobilized with the 80-kD
AKAP protein according to the method of Beall and Mitchell (Beall and
Mitchell, 1986) as previously described (Yang et al., 1996). The purified
antibodies were then used in a recombinant AKAP100 immunoblot assay.
The immunoprecipitation assay was performed to characterize the rat
heart AKAP by using the anti-AKAP100 rabbit IgG antibodies and anti-
RII goat IgGs antibodies according to methods previously described
(Gray et al., 1997). Rat left ventricle homogenates (0.5 ml) were incubated
with 10 
 
m
 
g of the primary IgG antibodies followed by incubation with 100 
 
m
 
l
of Protein G Sepharose 4 Fast Flow™ gel (Pharmacia Biotech., Inc.) to
precipitate the antigen–antibody complexes. In addition, the cAMP-aga-
rose affinity copurification assay was also performed to identify the
AKAP100-RII complexes in the rat heart. cAMP-agarose beads (200 
 
m
 
l)
obtained from Sigma Chemical Co. were incubated with rat left ventricle
homogenates (0.5 ml) as described (Hausken et al., 1996). The RII-AKAP
complex–bound-Protein G Sepharose beads and cAMP-agarose were
washed three times with 1 ml Buffer A. The immunoprecipitated proteins
and copurified proteins were eluted by incubation with SDS-PAGE sam-
ple buffer (10 min at 95
 
8
 
C), and were then analyzed by immunoblotting
with anti-AKAP100 antibodies.
The murine RII
 
a
 
 recombinant plasmid (RII-pET11d) was a generous
gift of Dr. John D. Scott, (Vollum Institute, OR). The recombinant RII
was used to transform 
 
E. coli
 
 bacteria strain BL21(DE3). The RII recom-
binant protein was expressed under 2 mM isopropyl-b-D-thiogalactopy-
ranoside (IPTG) induction followed by affinity purification using cAMP-
agarose as described (Dransfield et al., 1997). The purified recombinant
RII was separated on SDS-PAGE gels, analyzed by Coomassie blue stain-
ing, and immunoblotted with RII-specific antibodies. Purified recombi-
nant RII was labeled with [
 
32
 
P]ATP by in vitro phosphorylation using
PKA catalytic subunits obtained from Sigma Chemical Co. as described
(Bregman et al., 1989). The reaction was carried out at 30
 
8
 
C for 2 h. An
RII overlay assay was then performed following methods previously de-
scribed (Keryer et al., 1993) to determine the interaction between the RII
and AKAP100 recombinants. The RII-binding proteins were detected by
PhosphorImaging (Molecular Dynamics, Inc., Sunnyvale, CA). The inhib-
itory Ht 31 peptide (1 
 
m
 
M), synthesized according to the published se-
quence (Carr et al., 1992), was used to compete with the RII-AKAP100
binding in the RII overlay assay.
 
Cloning and Characterization of Human
AKAP100 Recombinant
 
Human AKAP100 cDNA was generated by RT-PCR using human heart
poly(A)
 
1
 
 RNA as templates and primers flanking the published
AKAP100 coding region (McCartney et al., 1995). Total RNA was iso-
lated from left ventricles of the unmatched organ donor by using TRIzol
reagent (Gibco Laboratories, Grand Island, NY). Poly(A)
 
1
 
 RNA was pu-
rified from total RNA by oligo(dT)-cellulose chromatography (Qiagen,
Inc., Valencia, CA). The primers were designed to create a BamHI site at
the 5
 
9
 
-end (5
 
9
 
-CGGGATCCCGATGTCCTTTACTGGCCAGATGTC-
3
 
9
 
) and a BglII site at the 3
 
9
 
-end (5
 
9
 
-GAAGATCTTCGGGGA-
GGGGGTACATTCTACCTATGC-3
 
9
 
). The amplified human AKAP100
cDNA (2 kb) was cloned into pCR2.1 vector (Invitrogen Corp., San
Diego, CA). To confirm that the isolated cDNA was from AKAP100, the
cDNA insert was sequenced in both directions by an automatic sequencer.
The pCR2.1 vector-specific T7 promoter primer and M13 reverse primer
were used for the initial sequencing, and subsequent primers were synthe-
sized on the basis of the cDNA sequence. The oligonucleotides for se-
quencing were purchased from Gibco Laboratories. The DNA sequence
was then aligned to the published AKAP100 cDNA using computer soft-
ware (DNASTAR Inc., Madison, WI). The AKAP100 cDNA insert was
then subcloned into BamHI and BglII sites of the expression vector
pRSET C (Invitrogen Corp.). In this construct, the vector contributes a 6
histidine tag to the NH
 
2
 
-terminus of the recombinant, as described (Yang
et al., 1996). An enterokinase cleavage site is located two amino acid re-
sidues upstream of the AKAP100 recombinant. The recombinant
AKAP100 plasmid was then used to transform 
 
E. coli
 
 bacteria strain
BL21(DE3). The AKAP100 recombinant protein was expressed under 2
 
mM IPTG induction for 2 h. The AKAP100 recombinant bacterial lysates
were separated on a preparative SDS-PAGE gel followed by immuno-
blotting with anti-AKAP100 antibodies and anti-6 His tag monoclonal an-
tibody. The AKAP100 recombinant was further characterized by using
the RII overlay assay.
 
Cryostat Sections of Rat Papillary Muscles
 
Cryostat sections from Sprague-Dawley rat left ventricle papillary muscles
were prepared as previously described (Carl et al., 1995). In brief, adult
Sprague-Dawley rats were killed, and the left ventricle was washed with
ice-cold relaxing solution (0.1 M KCl, 5 mM EGTA, 5 mM MgCl
 
2
 
, 3 mM
2,3-butanedione monoxime, 0.25 mM DTT, and 10 mM histidine at pH
6.8) as described (Gwathmey et al., 1991). Papillary muscles were dis-
sected at approximately resting sarcomere length. After equilibration for
5 min in the relaxing solution, the tissue strips were mounted on cork
specimen holders using gum tragacanth. The isolated papillary muscle was
flash-frozen in liquid nitrogen–cooled isopentane. The papillary muscle
was sectioned either longitudinally or transversely with a section thickness
of 8 
 
m
 
m using a Microm cryostat (Carl Zeiss, Inc., Batavia, IL). Frozen
sections were collected on Superfrost Plus glass slides (Baxter Diagnos-
tics, Inc., Deerfield, IL).
 
Immunofluorescence Labeling
 
To determine the subcellular localization of AKAP100 in the heart, im-
munostaining and confocal laser scanning microscopy were performed on
isolated adult rat ventricular myocytes and on cryostat sections from pap-
illary muscles from hearts of Sprague-Dawley rats. Freshly isolated car-
diac myocytes were adsorbed to Superfrost Plus glass slides for 20 min at
room temperature. To enhance the attachment of the myocytes, the glass
slides were pretreated with 0.1% poly-
 
l
 
-lysine obtained from Sigma
Chemical Co., followed by extensive washing in distilled water. The myo-
cytes or the cryostat sections were fixed on the slides with freshly pre-
pared fixative solution (4% paraformaldehyde and 4% sucrose in PBS,
pH 7.4) for 20 min at room temperature, followed by three PBS washes of
10 min each. Unreactive sites were blocked with 3% BSA in PBS for 1 h at
room temperature. To enhance antibody penetration of the myocytes, Tri-
ton-X 100 at a final concentration of 0.6% was added to the blocking solu-
tion. Since there is no membrane barrier in the cells of the cryostat sec-
tions, Triton-X 100 was not used for blocking of these samples.
The myocytes or the cryostat sections were incubated with primary an-
tibodies diluted in 3% BSA in PBS overnight at 4
 
8
 
C. The concentration of
the primary antibodies was as follows: 29 
 
m
 
g/ml anti-AKAP100 antibod-
ies, 20 
 
m
 
g/ml anti-RI antibodies, 25 
 
m
 
g/ml anti-RII antibody, 17 
 
m
 
g/ml
anti-RyR antibody, and 34 
 
m
 
g/ml anti-
 
a
 
-actinin antibody. After intensive
washing with PBS as described above, the myocytes were incubated with
FITC- or LRSC-conjugated secondary antibodies for 1 h at room temper-
ature. The concentration of the antibodies was 15 
 
m
 
g/ml LRSC-conju-
gated donkey anti–rabbit IgG, 26 
 
m
 
g/ml FITC-conjugated donkey anti–
mouse IgG, and 15 
 
m
 
g/ml FITC-conjugated donkey anti–goat IgG. After
washing off the unbound secondary antibodies, the myocytes or the cryo-
stat sections were mounted in VectaShield mounting medium (Vector
Labs, Inc., Burlingame, CA). For double immunostaining, the slides were
sequentially stained with two individual primary antibodies, followed by
simultaneous incubation with two secondary antibodies. Because phalloi-
din has high affinity and specificity for 
 
b
 
-actin, FITC-phalloidin (1 U/
slide) was directly added to the blocking solution for immunostaining the
thin filaments of the myocytes.
The immunostained slides were examined using a Leica TCS-NT con-
focal laser scanning microscope with an 100
 
3
 
 objective lens (Leica Laser-
techik GmbH, Heidelberg, Germany). The thickness (depth) of the opti-
cal sections was 
 
z
 
400 nm. Confocal images of the samples were examined
along the z-axis with a step-size of 0.5 
 
m
 
m. The digitized image was ana-
lyzed using the Leica TCS-NT computer software. For comparison of dou-
ble-stained patterns, the images from FITC and TRITC channels were si-
multaneously acquired from the same area of the sample, and were
superimposed. Since the binding affinity of the antibodies may affect the
intensity of the staining, in order to obtain optimally superimposed im-
ages, the intensity of the signals from each channel was balanced before
merging.
To determine the specificity of the AKAP100 and RII staining, cryostat
sections of the rat left ventricles were immunostained with anti-AKAP100
antibodies or anti-RII antibodies in the presence of 200 
 
m
 
l of recombinant
AKAP100 or RII bacterial lysates, respectively. In addition, as negative 
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controls, the myocytes and the cryostat sections were incubated with sec-
ondary antibodies only. Negative control slides were observed for each
experiment.
All confocal images shown in this study represent results from at least
three independent experiments. Negative controls stained only with sec-
ondary antibodies were observed at the same brightness and contrast set-
tings as the stained slides in all experiments. No specific staining was ob-
served in the negative controls (data not shown).
 
Results
 
Specificity of the Anti-RI and Anti-RII Antibodies
 
Specificity of the RI- and RII-specific antibodies in adult
Sprague-Dawley rat heart was determined by immunoblot
analysis. The anti-RI antibody specific for the RI
 
a
 
 and
RI
 
b
 
 isoforms recognized two protein bands with apparent
molecular masses of 49 and 53, respectively, in the rat
heart (Fig. 1, lane 
 
1
 
). Consistent with previous findings of
RI
 
a
 
 and RI
 
b
 
 isoforms in rat testes and brain (Skalhegg
et al., 1992; DeManno et al., 1994), and according to the
migration pattern of the doublets on the RI immunoblot
(Fig. 1, lane 
 
1
 
), the 49-kD and 53-kD protein bands should
represent the 
 
a
 
 and 
 
b
 
 isoforms of the RI subunits. By im-
munoblotting, the RII-specific antibodies recognized one
protein band of 
 
z
 
54 kD in the rat heart extracts (Fig. 1 
 
A
 
,
lane 
 
2
 
). Our results are consistent with previous studies
(Jahnsen et al., 1985; De Camilli et al., 1986) that showed
only one RII isoform present in the rat heart.
 
Identification of AKAP100 in Adult Hearts
 
It has previously been reported that human AKAP100–
specific antibodies bind to a protein with an apparent mo-
lecular mass of 100 in the rat embryonic cardiac H9c2 cell
line and skeletal L6P cell line (McCartney et al., 1995). By
immunoblotting, we showed that the anti-AKAP100 rab-
bit antibodies bound to a single protein band of 
 
z
 
80 kD in
rat ventricular myocyte extracts (Fig. 1 
 
A
 
, lane 
 
3
 
). Expres-
sion of AKAP100 in rat heart tissue was further examined
in homogenates of left ventricles from adult Sprague-
Dawley rats. As shown in Fig. 2 
 
A
 
, the anti-AKAP100 an-
tibodies also react to one protein in the rat heart homoge-
nates (lane 
 
3
 
), with a mobility on the gel consistent with
the protein identified in the myocyte extract (Fig. 1, lane
 
3
 
). According to the unstained molecular weight markers
on the same gel (Fig. 2 
 
A
 
, lane 
 
1
 
), the size of the protein
recognized by the anti-AKAP100 antibodies is estimated
to be 80 kD (lane 
 
3
 
). On the same immunoblot, the
AKAP100-specific antibodies bound to a slightly larger
protein (
 
z
 
82 kD) in homogenates obtained from the left
ventricle of a human donor heart (Fig. 2 
 
A
 
, lane 
 
2
 
). These
results were reproducible in four different Sprague-Daw-
ley rats, one failing, and one nonfailing human heart (data
not shown). Because AKAP100 proteins appear to be very
labile in the tissues, fresh tissue homogenates were used
for these studies.
Figure 1. Immunoblot analy-
sis of RI, RII, and AKAP100
in adult hearts. Soluble frac-
tion of the rat left ventricle
extracts (lanes 1 and 2, from
a preparative gel) and crude
protein extracts from iso-
lated rat left ventricular myo-
cytes (lane 3, 50 mg/lane)
were separated on 10% SDS-
PAGE gels by using the mini
gel system (Bio-Rad Labora-
tories, Hercules, CA). The
immunoblots were incubated
with RI-specific monoclonal
antibody (lane 1; 0.25 mg/ml), RII-specific goat antibodies (lane 2;
10 mg/ml) and AKAP100-specific rabbit antibodies (lane 3; 3.5
mg/ml), respectively. The protein bands were visualized by color
development as described in the text (lanes 1 and 2) or by ECL
(lane 3). Molecular weight markers are in kD.
Figure 2. Immunoblot, immunoprecipitation, and cAMP-agarose
copurification analyses of AKAP100 in the rat heart. In A, hu-
man (lane 2) and rat (lane 3) left ventricle homogenates were
separated on a 10% SDS-PAGE gel (100 mg/lane) followed by
immunoblotting with anti-AKAP100 antibodies. Unstained mo-
lecular weight markers were loaded on lane 1. In B, rat left ven-
tricle homogenates (0.5 ml) were incubated with 10 mg of
AKAP100-specific rabbit IgGs (lane 1), 10 mg of RII-specific
goat IgGs (lane 2), and 200 ml of cAMP-agarose (lane 3). The
AKAP100-IgG complexes were precipitated by incubation with
Protein G Sepharose beads. The precipitated proteins were solu-
bilized from the agarose or sepharose beads with SDS-PAGE
sample buffer followed by immunoblotting with anti-AKAP100
antibodies. As controls for the assay, 2 mg of rabbit IgGs and goat
IgGs were loaded on lanes 4 and 5, respectively. Prestained mo-
lecular weight markers are loaded on lane 6. In C, human (lane 1)
and rat (lane 2) left ventricle homogenates and human AKAP100
recombinant bacterial lysates (lane 3) were separated on a 10%
SDS-PAGE gel (100 mg/lane) followed by immunoblotting with
anti-AKAP100 antibodies that have been previously preab-
sorbed by AKAP100 recombinant bacterial lysates. As a control,
2 mg of rabbit IgGs were loaded on lane 4. In D, AKAP100 re-
combinant bacterial lysates (50 mg/lane) were separated on a
10% SDS-PAGE gel followed by immunoblotting with affinity-
purified anti-AKAP100 IgGs as described in the text. The Hoefer
(A–C) and Bio-Rad (D) SDS-PAGE systems were used for these
studies. A and B represent different lanes from the same gel. The
protein bands in A–C were visualized by color development,
whereas the immunoblot shown in D was developed by ECL.
Molecular weight markers are in kD.
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An immunoprecipitation assay was performed to further
characterize AKAP100 in the rat heart. By immunoblot-
ting, the anti-AKAP100 antibodies recognized one 80-kD
protein precipitated by the AKAP100-specific antibodies
(Fig. 2 
 
B
 
, lane 
 
1
 
). No higher molecular weight protein was
recognized by the anti-AKAP100 antibodies in the precip-
itates (Fig. 2 
 
B
 
, lane 
 
1
 
). We further demonstrated that the
80-kD protein is an RII-binding protein. By immunoblot-
ting, the anti-AKAP100 antibodies recognized an 80-kD
protein immunoprecipitated by the RII-specific antibodies
(Fig. 2 
 
B
 
, lane 
 
2
 
). These results were verified in the cAMP-
agarose copurification assay. The anti-AKAP100 antibod-
ies specifically react to an 80-kD protein in the cAMP-aga-
rose copurified RII-AKAP complexes (Fig. 2 
 
B
 
, lane 
 
3
 
).
These studies demonstrate that the 80-kD rat heart pro-
tein recognized by the anti-AKAP100 antibodies is an
RII-binding protein.
 
Characterization of the Human AKAP100 
Recombinant Protein
 
To further characterize the AKAP100 proteins in the
adult hearts, and to determine the specificity of the anti-
AKAP100 antibodies, we have cloned the full-length
AKAP100 cDNA from the human heart by RT-PCR. One
base differs between our sequence and the published
AKAP100 cDNA sequence. A guanine-adenine transition
at position 1978 results in a conservative amino acid sub-
stitution of aspartic acid for asparagine. Our results sug-
gest that AKAP100 cDNA is highly conserved among in-
dividuals. The human AKAP100 cDNA was then subcloned
into an expression vector for generating AKAP100 recom-
binant protein. By immunoblotting (Fig. 3 
 
A
 
), one protein
band of 
 
z
 
120 kD was recognized by both anti-6 His tag
monoclonal antibody (lane 
 
1
 
) and anti-AKAP100 poly-
clonal IgGs (lane 
 
2
 
). Antibodies with different specificity
recognized a protein of the same size on a preparative
immunoblot, suggesting that a full-length AKAP100 re-
combinant was generated. To further characterize the
AKAP100 recombinant, we have generated and purified
the recombinant RII subunits by cAMP-agarose chroma-
tography. The eluate from the cAMP-agarose column was
separated by SDS-PAGE followed by Coomassie blue
staining and immunoblotting. As shown in Fig. 3 
 
B
 
, one
52-kD protein band was identified on the Coomassie blue–
stained gel (lane 
 
1
 
), and was recognized by the anti-RII
antibodies on the immunoblot (lane 
 
2
 
), suggesting that re-
combinant RII was purified. The purified RII recombinant
was phosphorylated in vitro (Fig. 3 
 
B
 
, lane 
 
3
 
). The 
 
32
 
P-
labeled RII subunits bound to the AKAP100 recombinant
in an RII overlay assay (Fig. 3 
 
A
 
, lane 
 
3
 
). The RII-
AKAP100 binding was inhibited by incubation with 1 
 
m
 
M
of the Ht31 inhibitory peptide (Fig. 3 
 
A
 
, lane 
 
4
 
). We have
thus obtained a functional AKAP100 recombinant.
The molecular weight of our AKAP100 recombinant pro-
tein (
 
z
 
120 kD) is similar to the size of the AKAP100 re-
combinant previously reported (McCartney et al., 1995),
but obviously larger than the 78-kD full-length AKAP100
predicted by the cDNA sequence (McCartney et al., 1995)
and larger than the 80–82 kD proteins that we identified by
using anti-AKAP100 antibodies in homogenates from adult
rat and human hearts. Immunoblotting of enterokinase-
digested AKAP100 recombinant demonstrated that the
NH
 
2
 
-terminal histidine tag significantly retards migration of
the recombinant on the SDS-PAGE gel (data not shown).
 
Specificity of the Anti-AKAP100 Antibodies
 
The anti-AKAP100 antibodies obtained from Upstate
Biotechnology were generated against human AKAP100
recombinant (McCartney et al., 1995). McCartney and col-
leagues have shown that AKAP100-specific antibodies
cross-react with AKAP100 in extracts from rat embryonic
skeletal and cardiac cell lines (McCartney et al., 1995).
Since we showed that the anti-AKAP100 antibodies rec-
ognized smaller proteins in the adult hearts when com-
pared with one in the cell lines, we examined specificity of
the anti-AKAP100 antibodies in the rat heart. As shown
in Fig. 2 
 
C
 
, incubation of the anti-AKAP100 antibodies
with AKAP100 recombinant bacterial lysates depleted the
IgGs that recognized the 82-kD human heart protein (lane
 
1
 
), the 80-kD rat heart protein (lane 
 
2
 
), and the AKAP100
recombinant (lane 
 
3
 
). In a complementary experiment,
rabbit IgGs affinity-purified by using the 80-kD adult rat
heart AKAP, recognized the 120-kD AKAP100 recombi-
nant on the immunoblot (Fig. 2 
 
D
 
). These studies demon-
strate that (
 
a
 
) the 80-kD rat heart protein is of AKAP100
origin; and (
 
b
 
) the anti-AKAP100 antibodies are specific
for the AKAP in the rat heart.
Figure 3. Characterization of human AKAP100 and RII recom-
binant proteins. In A, human AKAP100 recombinant bacterial
lysates were analyzed by immunblotting (lanes 1 and 2, from a
preparative gel) and RII overlay (lanes 3 and 4, 100 mg/lane) as-
says. Lanes 1 and 2 were incubated with anti-6 His tag antibody
and anti-AKAP100 antibodies, respectively. The protein bands
were visualized by ECL. The RII overlay assay was performed as
described in the text with (lane 4) or without (lane 3) the inhibi-
tory peptide Ht31. The 32P-labeled RII binding protein was de-
tected by PhosphorImaging (Molecular Dynamics, Inc.). In B,
purified RII recombinant protein was analyzed by Coomassie
blue staining (lane 1, 50 mg/lane) and immunoblotting (lane 2, 10
mg/lane) with anti-RII antibodies. The protein band was visual-
ized by ECL. Lane 3 was loaded with 10 ml of 32P-labeled RII,
which was detected by PhosphorImaging. Molecular weights are
in kD.The Journal of Cell Biology, Volume 142, 1998 516
Immunolocalization of AKAP100 in Longitudinal 
Sections of the Adult Rat Cardiac Myocytes
AKAP100 was localized in adult rat hearts using indirect
immunofluorescence and laser scanning microscopy in cryo-
stat sections of rapidly frozen rat papillary muscles. In lon-
gitudinal sections, AKAP100 staining was evident in the
nucleus, cytoplasm, and at the intercalated disc of the
myocytes (Fig. 4). In the cytoplasm, AKAP100 staining
was observed predominantly as transverse bands, showing
a periodic striated pattern at z2-mm intervals (Fig. 4). Oc-
casionally, AKAP100 staining was also observed as longi-
tudinal connections between the transverse bands (Figs. 4
and 7 C, arrowheads). To verify our findings in rat papil-
lary muscles, we also determined the localization of
AKAP100 in freshly isolated left ventricular myocytes
from adult rat hearts. In longitudinal sections of the myo-
cytes, the AKAP100 staining was consistent with the
AKAP100 staining in the papillary muscles (data not
shown). The same AKAP100 staining pattern was also
seen in the subsequent studies described below.
Colocalization of RII and AKAP100 in Adult Rat Heart
Scott and coworkers observed that RII colocalized with
AKAP100 in the perinuclear region in rat H9c2 cells (Mc-
Cartney et al., 1995). However, we identified AKAP100 in
four distinct subcellular compartments of the adult rat car-
diac myocyte, suggesting that localization of RII in the
adult heart is very different from that in the embryonic
H9c2 cells. We also localized RI and RII subunits in
freshly isolated adult rat left ventricular myocytes. In lon-
gitudinal sections of the myocytes, RII staining showed a
periodic transverse pattern in the cytoplasm (Fig. 5 A),
very similar to the AKAP100 staining, though not identi-
cal (Fig. 5 B). Similar results were obtained in immu-
nostained transverse cryostat sections (Fig. 9, A and B). In
the superimposed image of RII/AKAP100 staining, the
majority of the AKAP100 and RII staining overlapped
(Fig. 5 C). Colocalization of RII-AKAP100 is also evident
in the nucleus, sarcolemma (Fig. 5, A and B), and at the in-
tercalated disc (data not shown) of the myocytes. Thus,
colocalized RII and AKAP100 are found in several dis-
tinct subcellular compartments in the adult rat heart. As
shown in Fig. 5 C, we also identified some nonoverlapping
RII and AKAP100 staining, which may suggest that RII
could be compartmentalized by AKAPs other than
AKAP100 in the cell. No AKAP100 and RII staining
was identified in the presence of an excess amount of re-
combinant AKAP100 and RII, respectively (data not
shown). These competition studies demonstrate that the
AKAP100 and RII staining shown in Figs. 4 and 5 is spe-
cific for AKAP100 and RII in the cardiac myocytes.
In contrast, RI staining was observed only in the cyto-
plasm, with no RI staining in the nucleus (Fig. 5 D). In the
cytoplasm, the RI staining had a diffuse longitudinal pat-
tern with no evidence of periodic cross-striations (Fig. 5 D,
arrowheads). This longitudinal RI staining pattern sug-
gests that RI may be distributed in a region close to the
myofibrils. Our studies demonstrate that RI is not colocal-
ized with AKAP100, and that RI and RII are most likely
located in distinct subcellular compartments in the adult
rat heart.
AKAP100 Is Localized at the Level of the Z-line in 
Cardiac Muscle Cell
To align the transverse periodic AKAP100 staining to spe-
cific sarcomeric components, we immunostained freshly
isolated adult rat left ventricular myocytes with FITC-
phalloidin and AKAP100-specific antibodies. Phalloidin
has a high affinity for F-actin in thin filaments. As ex-
pected, in the phalloidin-stained image, the longitudinally
orientated thin filaments are visualized as periodic thick
bands (Fig. 6 A). The unstained region of the myofibrils
represents the H-zone at the center of the A-band, the
area of the sarcomere where there are no thin filaments
(Fig. 6 A). There was no phalloidin staining in either the
nucleus or the interfibrillar space (Fig. 6 A). In the cyto-
plasm, the transverse periodic AKAP100 staining is shown
as continuous lines crossing the myofibrils (Fig. 6 B). In
the superimposed image of the phalloidin/AKAP100 stain-
ing, the AKAP100 staining aligns with the center of the
phalloidin-stained thin filaments (Fig. 6 C), suggesting that
AKAP100 is localized at the level of the Z-line. In Fig. 6
C, AKAP100 staining is also identified in the nucleus and
in the sarcolemma where there is no evidence of phalloi-
din staining. These studies suggest that the periodic
AKAP100 staining is at the level of the Z-line, but that
AKAP100 may not be directly associated with the myo-
fibrils in the heart.
Figure 4. Immunolocalization of AKAP100 in longitudinal sec-
tions of the rat papillary muscle. Longitudinal sections of rat
papillary muscles were immunostained with AKAP100-specific
rabbit antibodies and examined by confocal microscopy. Local-
ization of the primary antibodies was detected with LRSC-conju-
gated donkey anti–rabbit IgG antibodies. The transverse periodic
staining (T), the nuclear staining (N), and the intercalated disc
staining (I) are indicated. Arrowheads label the AKAP100 stain-
ing between the transverse staining. Bar, 5 mm.Yang et al. AKAP100 in Multiple Subcellular Compartments of the Heart 517
Colocalization of AKAP100 with a-Actinin and RyR 
in Longitudinal Sections of Cardiac Myocytes
a-Actinin is a major component of the Z-line of myofila-
ments (Tokuyasy et al., 1981). It can therefore serve as a
marker to help determine the localization of AKAP100 in
cardiac myocytes. We colocalized AKAP100 and a-actinin
in cryostat sections of papillary muscle. In longitudinal
sections, a-actinin staining showed a periodic transverse
pattern at 2-mm intervals in the cytoplasm of the myocytes
(Fig. 7 A). The a-actinin–specific antibody also detected
the protein at the intercalated disc (Fig. 7 A). No a-actinin
staining was observed in the nucleus or sarcolemma (Fig.
7, A and C). In the same sections, AKAP100 staining (Fig.
7  B) exhibited similar cytoplasmic staining patterns to
a-actinin (Fig. 4 A). Superimposed images of the a-actinin
(Fig. 7 A) and AKAP100 staining (Fig. 7 B) showed that
the a-actinin and AKAP100 transverse periodic staining
and intercalated disc staining overlapped (Fig. 7 C). In the
superimposed image, we also identified some longitudinal
AKAP100 staining (Fig. 7 C, arrowheads) similar to the
longitudinal staining in Fig. 4. This longitudinal AKAP100
staining pattern resembled the distribution of the longitu-
dinal components of the T-tubule network (Forbes et al.,
1984). These results further confirm that AKAP100 is lo-
calized at the level of the Z-line in the nucleus, in the sar-
colemma, and at the intercalated disc in the adult heart.
In adult cardiac myocytes, RyR is located in the junc-
tional SR, apposed to the T-tubule located at the level of
the Z-line (Opie, 1991; Takagishi et al., 1997). We therefore
used RyR as an additional marker to determine the location
of AKAP100 within the cardiac muscle cells. In longitudinal
sections of left ventricular myocytes, RyR-specific staining
was punctate and exhibited a periodic (z2 mm) transverse
pattern (Fig. 7 D). No RyR staining was evident in the nu-
cleus (Fig. 7 D). These results are consistent with previously
described RyR localization in the junctional SR in cardiac
muscle (Jorgensen et al., 1993). AKAP100 staining (Fig. 7
E) was very similar to the RyR staining pattern (Fig. 7 D).
In the RyR/AKAP100 double-stained cells, superimposed
images demonstrated that the periodic transverse patterns
of AKAP100 (Fig. 7 E) and RyR (Fig. 7 D) predominantly
overlapped (Fig. 7 F), although RyR staining was punctate
(Fig. 7 D, arrowheads), and AKAP100 staining (Fig. 7 E)
exhibited a continuous transverse pattern. Some of the dis-
crete punctate RyR staining did not colocalize with the
AKAP100 staining (Fig. 7 F ,  arrowheads). These results
suggest that AKAP100 may be localized in the region of the
T-tubule/junctional SR close to the RyR.
AKAP100 is in the T-tubule/Junctional SR in the 
Cardiac Myocytes
In longitudinal orientations, the staining patterns for
AKAP100 essentially overlapped with those of a-actinin
and RyR (Fig. 7), suggesting that all three proteins are lo-
Figure 5. Colocalization of RII
with AKAP100 and immunolo-
calization of RI in cardiac myo-
cytes. Freshly isolated adult rat
left ventricular myocytes were
double-stained with RII- (A)
and AKAP100-specific antibod-
ies (B), or with RI-specific anti-
body (D). The anti-AKAP100
rabbit antibodies were detected
with LRSC-conjugated donkey
anti–rabbit IgG antibodies. Lo-
calization of RI-specific mono-
clonal antibody and RII-specific
goat antibodies were visualized
by using FITC-conjugated don-
key anti–mouse IgG antibodies
and FITC-conjugated donkey
anti–goat IgG antibodies, re-
spectively. C is the superim-
posed image of A and B. The
transverse periodic staining (T),
sarcolemmal staining (S), and
the nuclear staining (N) are indi-
cated. In D, the longitudinal
staining pattern is labeled with
arrowheads, and the nucleus
without staining is labeled with
an N. Bar, 5 mm.The Journal of Cell Biology, Volume 142, 1998 518
cated at the level of the Z-line. However, because of su-
perposition of subcellular structures in the 400 nm–thick
optical sections, a longitudinal orientation does not permit
clear differentiation between a T-tubule/junctional SR
network or the Z-disc as the location of AKAP100. To dis-
tinguish between these two possibilities, cross-sections of
rat papillary muscle were double-immunostained with
AKAP100-specific antibodies plus a-actinin–specific, or
RyR-specific antibodies. a-Actinin staining was observed
in the cytoplasm, but not in the nucleus or sarcolemma
(Fig. 8 A). The stained regions represent the Z-discs of the
myofibrils, whereas the unstained regions are intramyo-
fibrillar space or myofibrils sectioned at regions other than
at the level of the Z-disc. As in longitudinal sections,
AKAP100 staining was observed in the cytoplasm, nu-
cleus, and at the sarcolemma (Fig. 8 B). In the cytoplasm
we identified a unique transverse AKAP100 staining pat-
tern originating at the sarcolemma, consistent with the lo-
cation of the T-tubule network (Fig. 8 B, arrowheads). In
superimposed images of the a-actinin/AKAP100 double
staining, the majority of the AKAP100 staining was dis-
tinct from and in the region surrounding the a-actinin
staining (Fig. 8 C, arrowheads). These findings indicate
that AKAP100 is not a major component of the Z-disc;
therefore, it is likely that AKAP100 is localized to the re-
gion of the T-tubule/junctional SR.
The T-tubule and junctional SR are found in a network
around and between the myofibrils (Opie, 1991). In trans-
verse sections of papillary muscles, the punctate RyR
staining exhibited a network pattern (Fig. 8 D), and the
AKAP100 staining showed a similar pattern (Fig. 8 E).
This network pattern of the AKAP100 staining is consis-
tent with the network pattern identified in the a-actinin/
AKAP100 double-staining (Fig. 8 B). Compared with
the punctate RyR staining (Fig. 8 D, arrowheads), the
AKAP100 staining was more continuous (Fig. 8 E, arrow-
heads). In the superimposed image of the AKAP100/RyR
double-stained cross-sections, some of the punctate RyR
stainings were obviously distinct from the AKAP100 stain-
ing (Fig. 8 F, arrowheads). Since AKAP100 does not colo-
calize with a-actinin, the similar network pattern of the
RyR and AKAP100 staining suggests the AKAP100 is lo-
calized to the region of the T-tubule/junctional SR.
Finally, we also investigated colocalization of RII and
AKAP100 in the transverse cryostat sections of the rat pap-
illary muscles. As we expected, both RII and AKAP100
staining exhibit very similar network patterns (Fig. 9, A and
B), which are consistent with (a) the AKAP100 staining in
the region of the T-tubule/junctional SR network identi-
fied in Fig. 8, and (b) the RII-AKAP100 colocalization
identified in the longitudinal sections of the cardiac myo-
cytes (Fig. 5, A–C).
Discussion
We have shown for the first time the expression of
AKAP100 in adult rat and human hearts. Our studies con-
sistently demonstrate that the apparent molecular weights
of AKAP100 from adult rat and human hearts (Fig. 1) are
very similar to the 78-kD protein predicted by the
AKAP100 cDNA sequence, but less than the 100-kD pro-
tein previously reported in the H9c2 cell line. No higher
molecular weight protein was identified in the anti-
AKAP100 antibody-precipitated rat heart homogenates
(Fig. 2 B). By RII immunoprecipitation and cAMP-aga-
rose copurification assays, we have specifically shown that
the 80-kD rat heart protein is an RII-binding protein (Fig.
2 B). We have further characterized the 80-kD rat AKAP
by using recombinant human AKAP100. Results of the re-
combinant AKAP100 depletion and the affinity purifica-
tion of anti-AKAP100 antibodies studies (Fig. 2, C and
D) demonstrate that the 80-kD rat heart protein is of
AKAP100 origin. This finding was further supported by
our enterokinase digestion studies. An z30-kD histidine
tag was generated from the z120-kD fusion protein by the
enzyme digestion (data not shown). Our studies therefore
Figure 6. Localization of AKAP100 in the FITC-phalloidin–stained cardiac myocytes. Freshly isolated adult rat left ventricular myo-
cytes were incubated with FITC-phalloidin (A) followed by immunostaining with AKAP100-specific rabbit antibodies (B). Localization
of the anti-AKAP100 antibodies was detected with LRSC-conjugated donkey anti–rabbit IgG antibodies. C is the superimposed image
of A and B. In A, the location of the Z-line at the center of phalloidin staining is indicated (Z), and the nucleus without staining is la-
beled with an N. In A and C, transverse periodic staining (T), sarcolemmal staining (S), and nuclear staining (N) are shown. Bar, 5 mm.Yang et al. AKAP100 in Multiple Subcellular Compartments of the Heart 519
suggest that the size of AKAP100 in the mature adult
heart is significantly ,100 kD.
Developmental regulation of cardiac proteins, e.g.,
troponin I and troponin T, is an important characteristic of
maturation of the mammalian heart (Murphy, 1996). In
addition, posttranscriptional modification has previously
been reported for certain AKAPs, e.g., AKAP82 (Johnson
et al., 1997a). Johnson and colleagues also demonstrated
that a 26-kD NH2-terminal fragment from pro-AKAP82
(109 kD) is cleaved off during spermiogenesis, and
AKAP80 is observed as an 82-kD protein in epididymal
sperm (Johnson et al., 1997a). From these studies, it is
therefore reasonable to speculate that similar modification
could occur in AKAP100.
The molecular weights of the human and rat AKAP100
homologues are slightly different (Fig. 2 A). By Northern
blotting, human AKAP100 cDNA weakly hybridized to
rat heart mRNA (data not shown). Therefore, there may
be species differences in the amino acid sequence of
AKAP100 between rat and human. It has been shown that
AKAP is a family of heterogeneous proteins. Other than
the amphipathic helix motif responsible for the RII-
AKAP interaction, there is no overall similarity in nucle-
otide sequence among the identified AKAPs. Studies have
shown that AKAP75, AKAP79, and AKAP150 are bo-
vine, human, and rat homolgues, respectively (Rubin,
1994). The similarities and differences between the rat and
human AKAP100 homolgues will be elucidated once the
nucleotide sequence of the rat AKAP100 is determined.
By immunoblotting, we show that the 49-kD RIa, 53-kD
RIb, and the 54-kD RIIa subunit are present in adult rat
hearts (Fig. 1). These findings are consistent with previous
demonstrations of RI and RII studies in the rat (Skalhegg
et al., 1992; DeManno et al., 1994; Jahnsen et al., 1985; De
Figure 7. Colocalization of AKAP100 with a-actinin and RyR in longitudinal sections of cardiac myocytes. Longitudinal cryostat sec-
tions of rat papillary muscles (A–C) or freshly isolated adult rat left ventricular myocytes (D–F) were double-immunostained with either
a-actinin–specific (A) and AKAP100-specific (B) antibodies or RyR-specific (D) and AKAP100-specific (E) antibodies. The anti-
AKAP100 rabbit antibodies were detected with LRSC-conjugated donkey anti–rabbit IgG antibodies. Localization of the RyR- and
a-actinin-specific monoclonal antibodies were visualized by using FITC-conjugated donkey anti–mouse IgG antibodies. C is the super-
imposed image of A and B; F combines from the images in D and E. Transverse periodic staining (T), sarcolemmal staining (S), nuclear
staining (N), and intercalated disc staining (I) are indicated. In C, arrowheads indicate the longitudinal AKAP100 staining localized be-
tween the transverse staining, whereas in D and F, arrowheads label the punctate RyR staining. The nucleus without staining is labeled
with an N. Bar, 5 mm.The Journal of Cell Biology, Volume 142, 1998 520
Camilli et al., 1986). By immunostaining and confocal mi-
croscopy, we identify RI- and RII-specific staining in rat
cardiac myocytes, thus confirming expression of both RI
and RII subunits in the adult heart.
In contrast to previous findings in the H9c2 cardiac cell
line where AKAP100 was associated with RII in a perinu-
clear location (McCartney et al., 1995), we have shown
that RII colocalizes with AKAP100 in multiple subcellular
compartments in adult hearts (Fig. 3). Because the RII
and AKAP100 staining patterns are very similar (Fig. 3),
our results also suggest that AKAP100 is likely to be the
major PKA II anchor in the heart.
The cytoplasmic RI staining and lack of RI nuclear
staining observed in our studies are consistent with previ-
ous findings by Meinkoth and colleagues (Meinkoth et al.,
1990). These authors demonstrated that RI subunits serve
as anchors that sequester C subunits in the cytoplasm until
the holoenzyme dissociates in response to increased
cAMP, and the dissociated C subunits are then trans-
ported into the nucleus. Our results suggest that RI may
be associated with myofilaments (Fig. 5 D). It has recently
been shown that RI may bind to AKAPs with low affinity
(Burton et al., 1997), and that D-AKAP1 can simulta-
neously bind RI and RII (Huang et al., 1997). It is there-
fore possible that RI is compartmentalized in rat cardiac
myocytes by mechanisms yet to be determined. One of the
major findings from our studies is that we have identified
that RI and RII subunits are distributed differently in the
cardiac myocytes, implying that PKA I and II may have
different functions in the heart.
In addition to AKAP100 localization in the cytoplasm,
we also localized AKAP100 to the nuclei of cardiac myo-
cytes. Nuclear localization of AKAP100 may be a feature
of the differentiated cardiac myocyte, but not the embry-
onic cardiac H9c2 cell line. Previous studies have shown
nuclear distributions for AKAPs (Coghlan et al., 1994;
Figure 8. Colocalization of AKAP100 with a-actinin and RyR in cross-sections of cardiac myocytes. Cross-sections of the rat papillary
muscle were double-immunostained with either a-actinin–specific (A) and AKAP100-specific (B) antibodies or RyR-specific (D) and
AKAP100-specific (E) antibodies. The primary antibodies were detected as described in Fig. 5. C is the superimposed image of A and
B; F is combined from the images in D and E. The myocytes are labeled as in Fig. 5. In B, arrowheads indicate the network pattern of
the AKAP100 staining, which is not seen in the a-actinin staining (A). In C, AKAP100 staining localized in the boundary of the a-acti-
nin staining is indicated by arrowheads. In D and E, arrowheads indicate the similar RyR and AKAP100 network staining. In F, arrow-
heads indicate the punctate RyR staining that does not overlap with the AKAP100 staining. Bar, 5 mm.Yang et al. AKAP100 in Multiple Subcellular Compartments of the Heart 521
Zhang et al., 1996). Our results suggest that AKAP100
may be another nuclear AKAP, although distinct from
AKAP95, since AKAP100 is also found in the cyto-
plasm.  Our studies therefore demonstrate the diversity of
AKAP100-dependent PKA II compartmentalization, and
suggest that AKAP100 may have different regulatory
functions at different sites in the adult heart.
By double immunostaining of cardiac myocytes with
AKAP100-specific antibodies and FITC-phalloidin (Fig.
6), and also by colocalization of AKAP100 with a-actinin
and with RyR (Fig. 7), we have shown that AKAP100 is
localized in the region of the T-tubule/junctional SR in
adult ventricular myocytes (Fig. 8). L-type Ca21 channels
in the sarcolemma and T-tubule play an important role in
excitation–contraction coupling in striated muscle cells
(Opie, 1991). Recent studies demonstrated that disruption
of RII-AKAP binding with an inhibitory peptide, Ht31,
prevents time- and voltage-dependent modulation of the
skeletal muscle L-type Ca21 channel expressed in a kidney
cell line (Johnson et al., 1997b). In HEK293 cells trans-
fected with AKAP79, AKAP-dependent regulation of
cardiac L-type Ca21 channel was observed (Gao et al.,
1997). By immunoprecipitation and RII overlay, a 15-kD
AKAP15 was found to be associated with the L-type Ca21
channel in skeletal muscle (Gray et al., 1997). Since the
L-type Ca21 channel is a major PKA substrate in the heart
(Tsien et al., 1986), AKAP100 could potentially function
in tethering PKA II to this channel, or in the vicinity of the
channel, in cardiac myocytes.
In cryostat sections of papillary muscles, we also ob-
served AKAP100 staining in the sarcolemma and at the in-
tercalated disc of cardiac myocytes. The intercalated disc
is an area of intercellular junctions that facilitates intercel-
lular adhesion and communication. Careful ultrastructural
studies of cardiac myocytes at the EM level have revealed
that the sarcolemma can extend from the intercalated disc
of one myocyte into the T-tubule network of the adjacent
cell (Meddoff and Page, 1968). The T-tubule is an invagi-
nation of the myocyte membrane, and thus the sarco-
lemma, the intercalated disc, and the T-tubule network
can be considered to be an interconnected membrane sys-
tem, perhaps explaining the distribution of AKAP100 in
each of these subcellular compartments. In addition, it has
been shown that the Kv1.5 K1 channel is localized at the
intercalated disc of cardiac myocytes (Mays et al., 1995).
Activity of certain K1 channels is regulated by PKA phos-
phorylation (Chen and Yu, 1994; Chuang et al., 1991), and
thus localization of AKAP100 at the intercalated disc may
imply PKA regulation of the K1 channel in the cardiac
muscle cell.
It was initially believed that each AKAP contains two
main classes of binding sites: a conserved anchoring motif
that binds RII, and a targeting domain that directs subcel-
lular localization of the AKAP/PKA II complex (Dell’Ac-
qua and Scott, 1997; Rubin, 1994). According to the loca-
tion of known AKAPs, a targeting hypothesis was
proposed (Dell’Acqua and Scott, 1997; Faux and Scott,
1996). It suggests that the targeting domain is an essential
feature of each AKAP as it confers specificity by tethering
the anchored PKA complex to a particular organelle or lo-
cation in the cell. However, with the exception of a report
of putative targeting domains on AKAP75 (Glantz et al.,
1993), the portion of AKAP molecules responsible for tar-
geting remains to be identified.
We have shown that AKAP100 is located in multiple
subcellular compartments in cardiac myocytes, and also
that RII colocalizes with AKAP100 in the cardiac muscle
cells. Our findings therefore suggest that AKAP100 teth-
ers PKA II to several distinct subcellular compartments
rather than targeting PKA II to a single site. In order for
the AKAP100/PKA II complex to localize to multiple sites
in the cell, we propose that the AKAP100/PKA II com-
plex may associate with an unidentified molecule(s) com-
mon to a number of different regions in the cell.
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Figure 9. Colocalization of
RII with AKAP100 in cross-
sections of cardiac myocytes.
Transverse cryostat sections
of rat papillary muscles
were  double-immunostained
with RII-specific (A) and
AKAP100-specific (B) anti-
bodies. The primary antibod-
ies were detected as de-
scribed in Fig. 5. The arrows
label the nuclear staining (N)
for RII and for AKAP100.
The arrowheads indicates the
similar RII and AKAP100
network staining patterns.
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